1 study found for:
NCT00390221
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
|
† Indicates status has not been verified in more than two years